OTCPK:BMKDF (Canada)  
Biomark Diagnostics Inc logo

Biomark Diagnostics Inc

$ 0.12 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 12.36M
Enterprise V:
$ 12.82M
Volume:
-
Avg Vol (2M):
12.06K
Also Trade In:
Volume:
-
Market Cap $:
12.36M
PE Ratio:
At Loss
Avg Vol (2-Month):
12.06K
Enterprise Value $:
12.82M
PB Ratio:
0
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the advanced-stage cancer diagnostic business. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection.
Name Current Vs Industry Vs History
Cash-To-Debt 0.37
Equity-to-Asset -0.32
Debt-to-Equity -2.37
Debt-to-EBITDA -0.8
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.25
Distress
Grey
Safe
Beneish M-Score 0.17
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 12.97
9-Day RSI 20.47
14-Day RSI 25.95
6-1 Month Momentum % 11.61
12-1 Month Momentum % 34.06

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.35
Quick Ratio 0.35
Cash Ratio 0.3
Days Sales Outstanding 178.85

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -6.2
Name Current Vs Industry Vs History
Operating Margin % -1886.25
Net Margin % -2005
ROA % -144.32
ROIC % -177.24
ROC (Joel Greenblatt) % -252.17
ROCE % -14235.85

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 99.46
EV-to-EBIT -6.07
EV-to-EBITDA -7.43
EV-to-Revenue 114.61
EV-to-FCF -13.41
Earnings Yield (Greenblatt) % -16.47

Financials

BMKDF's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BMKDF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.063
EPS (TTM) ($) -0.017
Beta 0.85
Volatility % 66.06
14-Day RSI 25.95
14-Day ATR ($) 0.008341
20-Day SMA ($) 0.166785
12-1 Month Momentum % 34.06
52-Week Range ($) 0.123 - 0.23596
Shares Outstanding (Mil) 83.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biomark Diagnostics Inc Filings

Document Form Filing Date
No Filing Data

Biomark Diagnostics Inc Analysis

Share your research

Headlines

See More
No news.